Cargando…
Does alvimopan enhance return of bowel function in laparoscopic gastrointestinal surgery? A meta-analysis
BACKGROUND: Postoperative ileus (POI) remains a major impediment in patient recovery and leads to longer lengths of stay at the hospital, readmission rates, and hospital costs. Alvimopan, a mu-opioid receptor antagonist, lowers POI incidence following open gastrointestinal surgery, however, little i...
Autores principales: | Nguyen, Douglas L., Maithel, Shelley, Nguyen, Emily T., Bechtold, Matthew L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hellenic Society of Gastroenterology
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4585395/ https://www.ncbi.nlm.nih.gov/pubmed/26423597 |
Ejemplares similares
-
Outcomes of Alvimopan Use in Laparoscopic Intra-abdominal Surgery: A Retrospective Review
por: Kokan, Aamir A., et al.
Publicado: (2021) -
Delayed gastrointestinal recovery after abdominal operation – role of alvimopan
por: Berger, Nicholas G, et al.
Publicado: (2015) -
Management of postoperative ileus: focus on alvimopan
por: Marderstein, Eric L, et al.
Publicado: (2008) -
Prevention of Paralytic Ileus Utilizing Alvimopan Following Spine Surgery
por: Shah, Kalpit N., et al.
Publicado: (2015) -
Alvimopan in an Enhanced Recovery Program Following Radical Cystectomy
por: Hamilton, Zach, et al.
Publicado: (2015)